Please login to the form below

Not currently logged in
Email:
Password:

Biomunex appoints scientific and strategic advisors

Dr Sebastian Amigorena and Dr Dragan Grabulovski

Biomunex Dr Sebastian AmigorenaParis, France-based immuno-oncology specialist Biomunex Pharmaceuticals has appointed Dr Sebastian Amigorena and Dr Dragan Grabulovski as key scientific advisor and key strategic advisor, respectively.

Dr Amigorena (pictured right) is currently a research director at Le Centre National de la Recherché Scientifique (CNRS) and is director of the Inserm Immunity and Cancer Unit at the Institut Curie in Paris.

In his role as scientific advisory, he will help the company to leverage its 'Plug-and-Play' antibody platform for the development of Biomunex's immunotherapeutics pipeline.

Biomunex Dr Dragan GrabulovskiMeanwhile, Dr Grabulovski (pictured left) is a pharmaceutical biotechnology advisor at Grabulovski Consulting Services, having previously served as chief scientific officer of Covagen, which he co-founded.

Prior to Covagen's sales to Johnson & Johnson in 2014, Dr Grabulovski was responsible for the Swiss biotech's research and development strategy, including its Fynomer technology.

Dr Pierre-Emmanuel Gerard, chief executive officer at Biomunex, said: “We are very pleased to welcome Dr Amigorena and Dr Grabulovski as key advisors.

“As international key opinion leaders they will play an instrumental role as we advance our first oncology programmes into pre-clinical and clinical development."

22nd December 2016

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

A snapshot of… Exscientia
...
Patients are ready for virtual clinical trials, are you?
Traditional clinical trial designs simply can’t withstand the impact of COVID-19. While before the pandemic, some in clinical research were beginning to adopt virtual components, the move towards designing hybrid...
Keep your audiences close
How getting up close and personal with target audiences can fuel creativity...

Infographics